28386687|t|Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample
28386687|a|The purpose of this study was to identify the specific metabolic brain pattern characteristic for Parkinson's disease (PD): Parkinson's disease-related pattern (PDRP), using network analysis of [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) brain images in a cohort of Slovenian PD patients. Twenty PD patients (age 70.1 ± 7.8 years, Movement Disorder Society Unified Parkinson's Disease Motor Rating Scale (MDS-UPDRS-III) 38.3 ± 12.2; disease duration 4.3 ± 4.1 years) and 20 age - matched normal controls (NCs) underwent FDG-PET brain imaging. An automatic voxel-based scaled subprofile model / principal component analysis (SSM / PCA) was applied to these scans for PDRP - Slovenia identification. The pattern was characterized by relative hypermetabolism in pallidum, putamen, thalamus, brain stem, and cerebellum associated with hypometabolism in sensorimotor cortex, posterior parietal, occipital, and frontal cortices. The expression of PDRP - Slovenia discriminated PD patients from NCs (p < 0.0001) and correlated positively with patients ' clinical score (MDS-UPDRS-III, p = 0.03). Additionally, its topography agrees well with the original PDRP (p < 0.001) identified in American cohort of PD patients. We validated the PDRP - Slovenia expression on additional FDG-PET scans of 20 PD patients, 20 NCs, and 25 patients with atypical parkinsonism (AP). We confirmed that the expression of PDRP - Slovenia manifests good diagnostic accuracy with specificity and sensitivity of 85-90% at optimal pattern expression cutoff for discrimination of PD patients and NCs and is not expressed in AP. PDRP - Slovenia proves to be a robust and reproducible functional imaging biomarker independent of patient population. It accurately differentiates PD patients from NCs and AP and correlates well with the clinical measure of PD progression.
28386687	0	8	Abnormal	T033	C0205161
28386687	9	18	metabolic	T169	C0311400
28386687	19	24	brain	T023	C0006104
28386687	25	32	network	T040	C0598941
28386687	49	68	Parkinson's disease	T047	C0030567
28386687	70	81	replication	T080	C1883725
28386687	91	99	European	T098	C0239307
28386687	100	106	sample	T077	C2347026
28386687	127	132	study	T062	C2603343
28386687	140	148	identify	T080	C0205396
28386687	162	171	metabolic	T169	C0311400
28386687	172	177	brain	T023	C0006104
28386687	178	185	pattern	T082	C0449774
28386687	186	200	characteristic	T080	C1521970
28386687	205	224	Parkinson's disease	T047	C0030567
28386687	226	228	PD	T047	C0030567
28386687	231	266	Parkinson's disease-related pattern	T081	C0449782
28386687	268	272	PDRP	T081	C0449782
28386687	281	288	network	T040	C0598941
28386687	301	354	[18F]-fluorodeoxyglucose positron emission tomography	T060	C0872169
28386687	356	363	FDG-PET	T060	C0872169
28386687	365	370	brain	T023	C0006104
28386687	371	377	images	T170	C1704254
28386687	383	389	cohort	T098	C0599755
28386687	393	402	Slovenian	T083	C0037334
28386687	403	405	PD	T047	C0030567
28386687	406	414	patients	T101	C0030705
28386687	423	425	PD	T047	C0030567
28386687	426	434	patients	T101	C0030705
28386687	436	439	age	T032	C0001779
28386687	451	456	years	T079	C0439234
28386687	458	530	Movement Disorder Society Unified Parkinson's Disease Motor Rating Scale	T170	C3639714
28386687	532	545	MDS-UPDRS-III	T170	C3639714
28386687	560	576	disease duration	T079	C0872146
28386687	587	592	years	T079	C0439234
28386687	601	604	age	T032	C0001779
28386687	607	614	matched	T080	C1708943
28386687	615	630	normal controls	T096	C0009932
28386687	632	635	NCs	T096	C0009932
28386687	647	654	FDG-PET	T060	C0872169
28386687	655	668	brain imaging	T060	C0203860
28386687	673	718	automatic voxel-based scaled subprofile model	T075	C0026336
28386687	721	749	principal component analysis	T081	C0429865
28386687	751	754	SSM	T075	C0026336
28386687	757	760	PCA	T081	C0429865
28386687	783	788	scans	T060	C0441633
28386687	793	797	PDRP	T081	C0449782
28386687	800	808	Slovenia	T083	C0037334
28386687	809	823	identification	T080	C0205396
28386687	829	836	pattern	T081	C0449782
28386687	841	854	characterized	T052	C1880022
28386687	867	882	hypermetabolism	T033	C0342952
28386687	886	894	pallidum	T023	C0017651
28386687	896	903	putamen	T023	C0034169
28386687	905	913	thalamus	T023	C0039729
28386687	915	925	brain stem	T023	C0006121
28386687	931	941	cerebellum	T023	C0007765
28386687	958	972	hypometabolism	T033	C0347938
28386687	976	995	sensorimotor cortex	T023	C3499125
28386687	997	1015	posterior parietal	T023	C3853037
28386687	1017	1026	occipital	T029	C1184145
28386687	1032	1048	frontal cortices	T023	C0016733
28386687	1054	1064	expression	T078	C1254370
28386687	1068	1072	PDRP	T081	C0449782
28386687	1075	1083	Slovenia	T083	C0037334
28386687	1098	1100	PD	T047	C0030567
28386687	1101	1109	patients	T101	C0030705
28386687	1115	1118	NCs	T096	C0009932
28386687	1136	1146	correlated	T080	C1707520
28386687	1163	1171	patients	T101	C0030705
28386687	1174	1182	clinical	T080	C0205210
28386687	1183	1188	score	T081	C0449820
28386687	1190	1203	MDS-UPDRS-III	T170	C3639714
28386687	1234	1244	topography	T185	C0392918
28386687	1275	1279	PDRP	T081	C0449782
28386687	1292	1302	identified	T080	C0205396
28386687	1306	1314	American	T098	C0596070
28386687	1315	1321	cohort	T098	C0599755
28386687	1325	1327	PD	T047	C0030567
28386687	1328	1336	patients	T101	C0030705
28386687	1355	1359	PDRP	T081	C0449782
28386687	1362	1370	Slovenia	T083	C0037334
28386687	1371	1381	expression	T078	C1254370
28386687	1396	1403	FDG-PET	T060	C0872169
28386687	1404	1409	scans	T060	C0441633
28386687	1416	1418	PD	T047	C0030567
28386687	1419	1427	patients	T101	C0030705
28386687	1432	1435	NCs	T096	C0009932
28386687	1444	1452	patients	T101	C0030705
28386687	1458	1479	atypical parkinsonism	T047	C4302185
28386687	1481	1483	AP	T047	C4302185
28386687	1508	1518	expression	T078	C1254370
28386687	1522	1526	PDRP	T081	C0449782
28386687	1529	1537	Slovenia	T083	C0037334
28386687	1553	1572	diagnostic accuracy	T080	C0598285
28386687	1578	1589	specificity	T081	C1511884
28386687	1594	1605	sensitivity	T081	C1511883
28386687	1627	1634	pattern	T081	C0449782
28386687	1635	1645	expression	T078	C1254370
28386687	1675	1677	PD	T047	C0030567
28386687	1678	1686	patients	T101	C0030705
28386687	1691	1694	NCs	T096	C0009932
28386687	1719	1721	AP	T047	C4302185
28386687	1723	1727	PDRP	T081	C0449782
28386687	1730	1738	Slovenia	T083	C0037334
28386687	1778	1796	functional imaging	T060	C1517324
28386687	1797	1806	biomarker	T201	C0005516
28386687	1822	1829	patient	T101	C0030705
28386687	1830	1840	population	T098	C1257890
28386687	1871	1873	PD	T047	C0030567
28386687	1874	1882	patients	T101	C0030705
28386687	1888	1891	NCs	T096	C0009932
28386687	1896	1898	AP	T047	C4302185
28386687	1928	1936	clinical	T080	C0205210
28386687	1937	1944	measure	T081	C0079809
28386687	1948	1950	PD	T047	C0030567
28386687	1951	1962	progression	T046	C0242656